12 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
formulations, comparison ... considerations #pharmacology ... #table #medications ... #comparison #drugs ... pharmacotherapy #dermatology
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
lymphoma (DLBCL) - Management ... and Treatment Algorithm ... lymphoma #DLBCL #Management ... #Treatment #Algorithm ... #oncology #hematology
Multiple Myeloma - Treatment Algorithm
a) Newly Diagnosed Myeloma: Transplant Eligible
b) Newly Diagnosed Myeloma: Transplant Ineligible

doi: 10.1038/s41408-020-00359-2

#Multiple
Myeloma - Treatment Algorithm ... Myeloma #Treatment #Algorithm ... #management #hematology ... #oncology
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... Thiazide #CHF #Cardiology ... #Management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... #medications #table ... #decisionaid #cardiology ... #hematology #warfarin
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... Malignancy #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Melanoma Treatment Algorithm

Resectable vs Inoperable Disease

Matthew Ho, MD PhD @MatthewHoMD and Aakash Desai, MD @ADesaiMD

#Melanoma #Treatment
Melanoma Treatment Algorithm ... Melanoma #Treatment #Algorithm ... #Management #dermatology ... #oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... Suggested treatment algorithm ... Suggested treatment algorithm ... Anticoagulation #Management ... #Hematology #Oncology
REBEL Review 90: Weight Based 4 Factor PCC Dosing 

#Hematology #Management #Table #4FactorPCC #REBELReview #Pharmacology #Dosing
PCC Dosing #Hematology ... #Management #Table ... #REBELReview #Pharmacology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
#Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology